[go: up one dir, main page]

GB2479471B - Method for determining copy number variations - Google Patents

Method for determining copy number variations

Info

Publication number
GB2479471B
GB2479471B GB1107268.3A GB201107268A GB2479471B GB 2479471 B GB2479471 B GB 2479471B GB 201107268 A GB201107268 A GB 201107268A GB 2479471 B GB2479471 B GB 2479471B
Authority
GB
United Kingdom
Prior art keywords
copy number
number variations
determining copy
determining
variations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB1107268.3A
Other versions
GB2479471A (en
GB201107268D0 (en
Inventor
Richard P Rava
Brian Kent Rhees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Verinata Health Inc
Original Assignee
Verinata Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44307118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB2479471(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Verinata Health Inc filed Critical Verinata Health Inc
Priority to GB1118398.5A priority Critical patent/GB2485645B/en
Priority to GB1118396.9A priority patent/GB2485644B/en
Publication of GB201107268D0 publication Critical patent/GB201107268D0/en
Publication of GB2479471A publication Critical patent/GB2479471A/en
Application granted granted Critical
Publication of GB2479471B publication Critical patent/GB2479471B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00Subject matter not provided for in other groups of this subclass
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6872Methods for sequencing involving mass spectrometry
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • G06F19/10
    • G06F19/22
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10Ploidy or copy number detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10Sequence alignment; Homology search
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00Reactions characterised by their quantitative nature
    • C12Q2545/10Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/101Reactions characterised by their quantitative nature the purpose being quantitative analysis with an internal standard/control
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Algebra (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Physics (AREA)
  • Pure & Applied Mathematics (AREA)
GB1107268.3A 2010-01-19 2010-12-01 Method for determining copy number variations Expired - Fee Related GB2479471B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1118398.5A GB2485645B (en) 2010-01-19 2010-12-01 Improved identification of partial aneuploidies using a normalising sequence
GB1118396.9A GB2485644B (en) 2010-01-19 2010-12-01 Improved identification of chromosomal aneuploidies using a normalising sequence

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US29635810P 2010-01-19 2010-01-19
US36083710P 2010-07-01 2010-07-01
US40701710P 2010-10-26 2010-10-26
US45584910P 2010-10-26 2010-10-26
PCT/US2010/058609 WO2011090557A1 (en) 2010-01-19 2010-12-01 Method for determining copy number variations

Publications (3)

Publication Number Publication Date
GB201107268D0 GB201107268D0 (en) 2011-06-15
GB2479471A GB2479471A (en) 2011-10-12
GB2479471B true GB2479471B (en) 2012-02-08

Family

ID=44307118

Family Applications (5)

Application Number Title Priority Date Filing Date
GB1118398.5A Expired - Fee Related GB2485645B (en) 2010-01-19 2010-12-01 Improved identification of partial aneuploidies using a normalising sequence
GB1108795.4A Expired - Fee Related GB2479476B (en) 2010-01-19 2010-12-01 Simultaneous determination of aneuploidy and fetal fraction
GB1107268.3A Expired - Fee Related GB2479471B (en) 2010-01-19 2010-12-01 Method for determining copy number variations
GB1108794.7A Active GB2479080B (en) 2010-01-19 2010-12-01 Sequencing methods and compositions for prenatal diagnoses
GB1118396.9A Expired - Fee Related GB2485644B (en) 2010-01-19 2010-12-01 Improved identification of chromosomal aneuploidies using a normalising sequence

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GB1118398.5A Expired - Fee Related GB2485645B (en) 2010-01-19 2010-12-01 Improved identification of partial aneuploidies using a normalising sequence
GB1108795.4A Expired - Fee Related GB2479476B (en) 2010-01-19 2010-12-01 Simultaneous determination of aneuploidy and fetal fraction

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB1108794.7A Active GB2479080B (en) 2010-01-19 2010-12-01 Sequencing methods and compositions for prenatal diagnoses
GB1118396.9A Expired - Fee Related GB2485644B (en) 2010-01-19 2010-12-01 Improved identification of chromosomal aneuploidies using a normalising sequence

Country Status (11)

Country Link
US (12) US20110224087A1 (en)
EP (14) EP2848704B1 (en)
AU (4) AU2010343276B2 (en)
CA (4) CA2786544C (en)
CY (1) CY1124494T1 (en)
DK (6) DK3492601T3 (en)
ES (6) ES2909841T3 (en)
GB (5) GB2485645B (en)
PL (4) PL3260555T3 (en)
TR (1) TR201807917T4 (en)
WO (3) WO2011090558A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8532936B2 (en) 2011-04-14 2013-09-10 Verinata Health, Inc. Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies
US10658070B2 (en) 2011-04-12 2020-05-19 Verinata Health, Inc. Resolving genome fractions using polymorphism counts

Families Citing this family (255)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005009324D1 (en) 2005-04-06 2008-10-09 Maurice Stroun Method for cancer diagnosis by detection of DNA and RNA in the circulation
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US8532930B2 (en) 2005-11-26 2013-09-10 Natera, Inc. Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
ATE508209T1 (en) * 2006-02-28 2011-05-15 Univ Louisville Res Found DETECTION OF CHROMOSOME ABNORMALITIES IN THE FETUS USING TANDEM SINGLE NUCLEOTIDE POLYMORPHISMS
WO2009105531A1 (en) * 2008-02-19 2009-08-27 Gene Security Network, Inc. Methods for cell genotyping
US8709726B2 (en) * 2008-03-11 2014-04-29 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
US20110092763A1 (en) * 2008-05-27 2011-04-21 Gene Security Network, Inc. Methods for Embryo Characterization and Comparison
US20110178719A1 (en) * 2008-08-04 2011-07-21 Gene Security Network, Inc. Methods for Allele Calling and Ploidy Calling
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
EP2473638B1 (en) 2009-09-30 2017-08-09 Natera, Inc. Methods for non-invasive prenatal ploidy calling
WO2011054936A1 (en) 2009-11-06 2011-05-12 The Chinese University Of Hong Kong Size-based genomic analysis
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
US9315857B2 (en) 2009-12-15 2016-04-19 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse label-tags
EP2516680B1 (en) 2009-12-22 2016-04-06 Sequenom, Inc. Processes and kits for identifying aneuploidy
US9260745B2 (en) 2010-01-19 2016-02-16 Verinata Health, Inc. Detecting and classifying copy number variation
US10388403B2 (en) 2010-01-19 2019-08-20 Verinata Health, Inc. Analyzing copy number variation in the detection of cancer
EP2513341B1 (en) 2010-01-19 2017-04-12 Verinata Health, Inc Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
WO2012135730A2 (en) 2011-03-30 2012-10-04 Verinata Health, Inc. Method for verifying bioassay samples
US20120100548A1 (en) 2010-10-26 2012-04-26 Verinata Health, Inc. Method for determining copy number variations
US9323888B2 (en) 2010-01-19 2016-04-26 Verinata Health, Inc. Detecting and classifying copy number variation
CA2786565C (en) 2010-01-19 2017-04-25 Verinata Health, Inc. Partition defined detection methods
WO2011090556A1 (en) 2010-01-19 2011-07-28 Verinata Health, Inc. Methods for determining fraction of fetal nucleic acid in maternal samples
EP2848704B1 (en) 2010-01-19 2018-08-29 Verinata Health, Inc Sequencing methods for prenatal diagnoses
US20110312503A1 (en) 2010-01-23 2011-12-22 Artemis Health, Inc. Methods of fetal abnormality detection
EP2572203B1 (en) * 2010-05-17 2017-10-25 The Board of Regents of The University of Texas System Determination of antigen-specific antibody sequences in blood circulation
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US8825412B2 (en) 2010-05-18 2014-09-02 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
WO2013052557A2 (en) * 2011-10-03 2013-04-11 Natera, Inc. Methods for preimplantation genetic diagnosis by sequencing
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11031095B2 (en) 2010-08-06 2021-06-08 Ariosa Diagnostics, Inc. Assay systems for determination of fetal copy number variation
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
US10533223B2 (en) 2010-08-06 2020-01-14 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US8700338B2 (en) 2011-01-25 2014-04-15 Ariosa Diagnosis, Inc. Risk calculation for evaluation of fetal aneuploidy
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US20130040375A1 (en) 2011-08-08 2013-02-14 Tandem Diagnotics, Inc. Assay systems for genetic analysis
US20140342940A1 (en) 2011-01-25 2014-11-20 Ariosa Diagnostics, Inc. Detection of Target Nucleic Acids using Hybridization
US10167508B2 (en) 2010-08-06 2019-01-01 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US11203786B2 (en) 2010-08-06 2021-12-21 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
EP3115468B1 (en) 2010-09-21 2018-07-25 Agilent Technologies, Inc. Increasing confidence of allele calls with molecular counting
KR101891847B1 (en) 2010-11-30 2018-08-24 더 차이니즈 유니버시티 오브 홍콩 Detection of genetic or molecular aberrations associated with cancer
CA2821906C (en) * 2010-12-22 2020-08-25 Natera, Inc. Methods for non-invasive prenatal paternity testing
US8756020B2 (en) 2011-01-25 2014-06-17 Ariosa Diagnostics, Inc. Enhanced risk probabilities using biomolecule estimations
US9994897B2 (en) 2013-03-08 2018-06-12 Ariosa Diagnostics, Inc. Non-invasive fetal sex determination
US11270781B2 (en) 2011-01-25 2022-03-08 Ariosa Diagnostics, Inc. Statistical analysis for non-invasive sex chromosome aneuploidy determination
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
US20230101627A1 (en) * 2011-01-25 2023-03-30 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
CA2824387C (en) 2011-02-09 2019-09-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9260753B2 (en) 2011-03-24 2016-02-16 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
AU2011365507A1 (en) * 2011-04-14 2013-05-02 Verinata Health, Inc. Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies
US9411937B2 (en) * 2011-04-15 2016-08-09 Verinata Health, Inc. Detecting and classifying copy number variation
US20130059738A1 (en) * 2011-04-28 2013-03-07 Life Technologies Corporation Methods and compositions for multiplex pcr
US20130059762A1 (en) 2011-04-28 2013-03-07 Life Technologies Corporation Methods and compositions for multiplex pcr
US9957558B2 (en) 2011-04-28 2018-05-01 Life Technologies Corporation Methods and compositions for multiplex PCR
CA2834218C (en) 2011-04-29 2021-02-16 Sequenom, Inc. Quantification of a minority nucleic acid species using inhibitory oligonucleotides
US20140235474A1 (en) 2011-06-24 2014-08-21 Sequenom, Inc. Methods and processes for non invasive assessment of a genetic variation
CA2840418C (en) * 2011-07-26 2019-10-29 Verinata Health, Inc. Method for determining the presence or absence of different aneuploidies in a sample
US8712697B2 (en) 2011-09-07 2014-04-29 Ariosa Diagnostics, Inc. Determination of copy number variations using binomial probability calculations
AU2012304328B2 (en) 2011-09-09 2017-07-20 The Board Of Trustees Of The Leland Stanford Junior University Methods for obtaining a sequence
US20130110407A1 (en) * 2011-09-16 2013-05-02 Complete Genomics, Inc. Determining variants in genome of a heterogeneous sample
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CA2850785C (en) 2011-10-06 2022-12-13 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
WO2013052913A2 (en) 2011-10-06 2013-04-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2624686T3 (en) 2011-10-11 2017-07-17 Sequenom, Inc. Methods and processes for the non-invasive evaluation of genetic variations
US8688388B2 (en) 2011-10-11 2014-04-01 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2013062856A1 (en) 2011-10-27 2013-05-02 Verinata Health, Inc. Set membership testers for aligning nucleic acid samples
AU2013209499B2 (en) * 2012-01-20 2018-05-10 Sequenom, Inc. Diagnostic processes that factor experimental conditions
WO2013130512A2 (en) 2012-02-27 2013-09-06 The University Of North Carolina At Chapel Hill Methods and uses for molecular tags
GB2513024B (en) 2012-02-27 2016-08-31 Cellular Res Inc A clonal amplification method
WO2013128281A1 (en) 2012-02-28 2013-09-06 Population Genetics Technologies Ltd Method for attaching a counter sequence to a nucleic acid sample
US9605313B2 (en) 2012-03-02 2017-03-28 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
PL2831279T3 (en) * 2012-03-26 2023-12-04 The Johns Hopkins University FAST DETECTION OF ANEUPLOIDIA
CN108485940B (en) * 2012-04-12 2022-01-28 维里纳塔健康公司 Detection and classification of copy number variation
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
DK3663409T3 (en) 2012-05-21 2021-12-13 Sequenom Inc METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10289800B2 (en) 2012-05-21 2019-05-14 Ariosa Diagnostics, Inc. Processes for calculating phased fetal genomic sequences
KR101705959B1 (en) * 2012-05-23 2017-02-10 비지아이 다이어그노시스 씨오., 엘티디. Method and system for identifying types of twins
US11261494B2 (en) * 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20140093873A1 (en) 2012-07-13 2014-04-03 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
WO2014015269A1 (en) 2012-07-19 2014-01-23 Ariosa Diagnostics, Inc. Multiplexed sequential ligation-based detection of genetic variants
CA2878246C (en) 2012-07-20 2022-01-11 Verinata Health, Inc. Detecting and classifying copy number variation in a cancer genome
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
EP4036247B1 (en) 2012-09-04 2024-04-10 Guardant Health, Inc. Methods to detect rare mutations and copy number variation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2014055790A2 (en) 2012-10-04 2014-04-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CN104871164B (en) * 2012-10-24 2019-02-05 南托米克斯有限责任公司 A genome browser system for processing and presenting nucleotide changes in genome sequence data
US10643738B2 (en) * 2013-01-10 2020-05-05 The Chinese University Of Hong Kong Noninvasive prenatal molecular karyotyping from maternal plasma
US20130309666A1 (en) * 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10240199B2 (en) 2013-02-28 2019-03-26 The Chinese University Of Hong Kong Maternal plasma transcriptome analysis by massively parallel RNA sequencing
EP2971100A1 (en) 2013-03-13 2016-01-20 Sequenom, Inc. Primers for dna methylation analysis
US9890425B2 (en) 2013-03-15 2018-02-13 Abbott Molecular Inc. Systems and methods for detection of genomic copy number changes
AU2014233373B2 (en) 2013-03-15 2019-10-24 Verinata Health, Inc. Generating cell-free DNA libraries directly from blood
US20140278127A1 (en) * 2013-03-15 2014-09-18 Battelle Memorial Institute Computer Files and Methods Supporting Forensic Analysis of Nucleotide Sequence Data
LT2981921T (en) 2013-04-03 2023-02-27 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2014190286A2 (en) 2013-05-24 2014-11-27 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20140371078A1 (en) 2013-06-17 2014-12-18 Verinata Health, Inc. Method for determining copy number variations in sex chromosomes
KR102784584B1 (en) 2013-06-21 2025-03-19 시쿼넘, 인코포레이티드 Methods and processes for non-invasive assessment of genetic variations
GB201318369D0 (en) * 2013-10-17 2013-12-04 Univ Leuven Kath Methods using BAF
GB2546833B (en) 2013-08-28 2018-04-18 Cellular Res Inc Microwell for single cell analysis comprising single cell and single bead oligonucleotide capture labels
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
US9499870B2 (en) 2013-09-27 2016-11-22 Natera, Inc. Cell free DNA diagnostic testing standards
US10964409B2 (en) 2013-10-04 2021-03-30 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9582877B2 (en) 2013-10-07 2017-02-28 Cellular Research, Inc. Methods and systems for digitally counting features on arrays
CN111863131A (en) 2013-10-07 2020-10-30 塞昆纳姆股份有限公司 Methods and procedures for non-invasive assessment of chromosomal alterations
SG10201804519RA (en) 2013-12-28 2018-07-30 Guardant Health Inc Methods and systems for detecting genetic variants
US11365447B2 (en) 2014-03-13 2022-06-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3957749A1 (en) 2014-04-21 2022-02-23 Natera, Inc. Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
EP3175000B1 (en) 2014-07-30 2020-07-29 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP3204512B1 (en) 2014-10-10 2020-05-06 Sequenom, Inc. Methods for partitioning of genomic sequences
US9857328B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
US9859394B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US10006910B2 (en) 2014-12-18 2018-06-26 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
US10020300B2 (en) 2014-12-18 2018-07-10 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US10429342B2 (en) 2014-12-18 2019-10-01 Edico Genome Corporation Chemically-sensitive field effect transistor
CA2976303A1 (en) 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
ES2975332T3 (en) 2015-02-19 2024-07-04 Becton Dickinson Co High-throughput single-cell analysis combining proteomic and genomic information
KR101533792B1 (en) * 2015-02-24 2015-07-06 대한민국 Method for Autosomal Analysing Human Subject of Analytes based on a Next Generation Sequencing Technology
EP3262192B1 (en) 2015-02-27 2020-09-16 Becton, Dickinson and Company Spatially addressable molecular barcoding
WO2016160844A2 (en) 2015-03-30 2016-10-06 Cellular Research, Inc. Methods and compositions for combinatorial barcoding
EP3286326B1 (en) 2015-04-23 2025-01-22 Becton, Dickinson and Company Method for whole transcriptome amplification
US10844428B2 (en) * 2015-04-28 2020-11-24 Illumina, Inc. Error suppression in sequenced DNA fragments using redundant reads with unique molecular indices (UMIS)
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
ES2990200T3 (en) 2015-05-22 2024-11-29 Medicover Public Co Ltd Multiplex parallel analysis of target genomic regions for noninvasive prenatal testing
WO2016196229A1 (en) 2015-06-01 2016-12-08 Cellular Research, Inc. Methods for rna quantification
EP3135770A1 (en) * 2015-08-28 2017-03-01 Latvian Biomedical Research and Study Centre Set of oligonucleotides and method for detection of fetal dna fraction in maternal plasma
US11302416B2 (en) 2015-09-02 2022-04-12 Guardant Health Machine learning for somatic single nucleotide variant detection in cell-free tumor nucleic acid sequencing applications
EP3347465B1 (en) 2015-09-11 2019-06-26 Cellular Research, Inc. Methods and compositions for nucleic acid library normalization
EP3378002A1 (en) * 2015-11-16 2018-09-26 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CN117174167A (en) 2015-12-17 2023-12-05 夸登特健康公司 Method for determining tumor gene copy number by analyzing cell-free DNA
US10982286B2 (en) 2016-01-22 2021-04-20 Mayo Foundation For Medical Education And Research Algorithmic approach for determining the plasma genome abnormality PGA and the urine genome abnormality UGA scores based on cell free cfDNA copy number variations in plasma and urine
CA3014773C (en) 2016-03-07 2025-11-18 Father Flanagan's Boys' Home Doing Business As Boys Town National Research Hospital Noninvasive molecular controls
JP7280044B2 (en) 2016-04-15 2023-05-23 ナテラ, インコーポレイテッド Method for detecting lung cancer
ES2956757T3 (en) 2016-05-02 2023-12-27 Becton Dickinson Co Accurate molecular barcode coding
WO2017201081A1 (en) 2016-05-16 2017-11-23 Agilome, Inc. Graphene fet devices, systems, and methods of using the same for sequencing nucleic acids
US10301677B2 (en) 2016-05-25 2019-05-28 Cellular Research, Inc. Normalization of nucleic acid libraries
ES2979395T3 (en) 2016-05-26 2024-09-25 Becton Dickinson Co Molecular tag count adjustment methods
WO2017205826A1 (en) 2016-05-27 2017-11-30 Sequenom, Inc. Methods for detecting genetic variations
US10640763B2 (en) 2016-05-31 2020-05-05 Cellular Research, Inc. Molecular indexing of internal sequences
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
US11200963B2 (en) 2016-07-27 2021-12-14 Sequenom, Inc. Genetic copy number alteration classifications
EP3491561A1 (en) 2016-07-27 2019-06-05 Sequenom, Inc. Methods for non-invasive assessment of genomic instability
US10683531B2 (en) * 2016-09-15 2020-06-16 ArcherDX, Inc. Methods of nucleic acid sample preparation for analysis of cell-free DNA
CA3037185A1 (en) 2016-09-15 2018-03-22 ArcherDX, Inc. Methods of nucleic acid sample preparation
US20220282305A1 (en) * 2016-09-15 2022-09-08 Archerdx, Llc Methods of nucleic acid sample preparation
CN109791157B (en) 2016-09-26 2022-06-07 贝克顿迪金森公司 Measuring protein expression using reagents with barcoded oligonucleotide sequences
US11854666B2 (en) 2016-09-29 2023-12-26 Myriad Women's Health, Inc. Noninvasive prenatal screening using dynamic iterative depth optimization
WO2018064629A1 (en) 2016-09-30 2018-04-05 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
CA3042391A1 (en) 2016-11-02 2018-05-11 ArcherDX, Inc. Methods of nucleic acid sample preparation for immune repertoire sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
CN109906274B (en) 2016-11-08 2023-08-25 贝克顿迪金森公司 Methods for cell marker classification
EP3539035B1 (en) 2016-11-08 2024-04-17 Becton, Dickinson and Company Methods for expression profile classification
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
WO2018132610A1 (en) 2017-01-13 2018-07-19 Cellular Research, Inc. Hydrophilic coating of fluidic channels
BR112019014651A2 (en) 2017-01-18 2020-07-21 Illumina, Inc. methods for sequencing nucleic acid molecules and for preparing sequencing adapters, a computer program product, and a computer system.
CA3049455C (en) 2017-01-20 2023-06-13 Sequenom, Inc. Sequencing adapter manufacture and use
US11929143B2 (en) 2017-01-20 2024-03-12 Sequenom, Inc Methods for non-invasive assessment of copy number alterations
CA3198931A1 (en) 2017-01-20 2018-07-26 Sequenom, Inc. Methods for non-invasive assessment of genetic alterations
IL319365A (en) 2017-01-24 2025-05-01 Sequenom Inc Methods and processes for assessment of genetic variations
CA3051509A1 (en) 2017-01-25 2018-08-02 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
WO2018144240A1 (en) 2017-02-01 2018-08-09 Cellular Research, Inc. Selective amplification using blocking oligonucleotides
US10894976B2 (en) 2017-02-21 2021-01-19 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
PT3596233T (en) 2017-03-17 2022-08-22 Sequenom Inc METHODS AND PROCESSES FOR EVALUATION OF GENETIC MOSAICIST
CA3058845A1 (en) * 2017-04-18 2018-10-25 Agilent Technologies Belgium Nv Use of off-target sequences for dna analysis
AU2018281745B2 (en) 2017-06-05 2022-05-19 Becton, Dickinson And Company Sample indexing for single cells
AU2018296673B2 (en) 2017-07-07 2025-01-02 Medicover Public Co Ltd Target-enriched multiplexed parallel analysis for assessment of risk for genetic conditions
WO2019008148A1 (en) 2017-07-07 2019-01-10 Nipd Genetics Public Company Limited Enrichment of targeted genomic regions for multiplexed parallel analysis
WO2019008172A1 (en) 2017-07-07 2019-01-10 Nipd Genetics Public Company Limited Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers
PL3649258T3 (en) 2017-07-07 2022-10-03 Nipd Genetics Public Company Limited Target-enriched multiplexed parallel analysis for assessment of fetal dna samples
JP7776099B2 (en) 2017-07-26 2025-11-26 ザ チャイニーズ ユニバーシティー オブ ホンコン Enhanced cancer screening using cell-free viral nucleic acid
HRP20210826T1 (en) 2017-07-26 2021-07-09 Trisomytest, S.R.O. PROCEDURE FOR NON-INVASIVE PRENATAL DETECTION OF FETAL CHROMOSOME OF MOTHER'S BLOOD-BASED ANEUPLOIDIA BASED ON BAYES NETWORK
US11519024B2 (en) 2017-08-04 2022-12-06 Billiontoone, Inc. Homologous genomic regions for characterization associated with biological targets
IL272399B2 (en) 2017-08-04 2025-03-01 Billiontoone Inc Sequencing, output definition and analysis of target-bound molecules in determining the amount associated with biological targets
EP3662479A1 (en) 2017-08-04 2020-06-10 Trisomytest, s.r.o. A method for non-invasive prenatal detection of fetal sex chromosomal abnormalities and fetal sex determination for singleton and twin pregnancies
CN111051511A (en) 2017-08-04 2020-04-21 十亿至一公司 Target-Associated Molecules for Characterization Related to Biological Targets
US11447818B2 (en) 2017-09-15 2022-09-20 Illumina, Inc. Universal short adapters with variable length non-random unique molecular identifiers
CN108733982B (en) * 2017-09-26 2021-02-19 上海凡迪基因科技有限公司 Pregnant woman NIPT result correction method and device, and computer-readable storage medium and equipment
JP2021500883A (en) 2017-10-27 2021-01-14 ジュノ ダイアグノスティックス,インク. Devices, systems, and methods for ultratrace liquid biopsy
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
US11946095B2 (en) 2017-12-19 2024-04-02 Becton, Dickinson And Company Particles associated with oligonucleotides
KR102031841B1 (en) * 2017-12-22 2019-10-15 테라젠지놈케어 주식회사 Method for determining fetal fraction in maternal sample
JP7164125B2 (en) 2018-01-05 2022-11-01 ビリオントゥーワン,インコーポレイテッド Quality control templates to ensure validity of sequencing-based assays
US12398389B2 (en) 2018-02-15 2025-08-26 Natera, Inc. Methods for isolating nucleic acids with size selection
CA3095030A1 (en) 2018-03-30 2019-10-03 Juno Diagnostics, Inc. Deep learning-based methods, devices, and systems for prenatal testing
AU2019248635B2 (en) 2018-04-02 2022-01-27 Illumina, Inc. Compositions and methods for making controls for sequence-based genetic testing
US12024738B2 (en) 2018-04-14 2024-07-02 Natera, Inc. Methods for cancer detection and monitoring
EP3788170B1 (en) 2018-05-03 2025-01-01 Becton, Dickinson and Company Molecular barcoding on opposite transcript ends
ES2945191T3 (en) 2018-05-03 2023-06-29 Becton Dickinson Co High-throughput multi-omics sample analysis
CN119955902A (en) * 2018-05-17 2025-05-09 伊鲁米纳公司 High-throughput single-cell sequencing with reduced amplification bias
JP7334122B2 (en) 2018-05-25 2023-08-28 イルミナ インコーポレイテッド A Circulating RNA Signature Specific to Preeclampsia
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
CA3108755C (en) 2018-08-06 2021-09-14 Billiontoone, Inc. Dilution tagging for quantification of biological targets
EP4471156A3 (en) 2018-10-01 2025-02-26 Becton, Dickinson and Company Determining 5' transcript sequences
WO2020097315A1 (en) 2018-11-08 2020-05-14 Cellular Research, Inc. Whole transcriptome analysis of single cells using random priming
WO2020113577A1 (en) * 2018-12-07 2020-06-11 深圳华大生命科学研究院 Method for constructing target gene library, detection device and application thereof
CN113195717A (en) 2018-12-13 2021-07-30 贝克顿迪金森公司 Selective extension in single cell whole transcriptome analysis
US11371076B2 (en) 2019-01-16 2022-06-28 Becton, Dickinson And Company Polymerase chain reaction normalization through primer titration
WO2020154247A1 (en) 2019-01-23 2020-07-30 Cellular Research, Inc. Oligonucleotides associated with antibodies
ES3013495T3 (en) 2019-01-31 2025-04-14 Guardant Health Inc Method for isolating and sequencing cell-free dna
EP3924506A1 (en) 2019-02-14 2021-12-22 Becton Dickinson and Company Hybrid targeted and whole transcriptome amplification
US11965208B2 (en) 2019-04-19 2024-04-23 Becton, Dickinson And Company Methods of associating phenotypical data and single cell sequencing data
WO2020226528A1 (en) * 2019-05-08 2020-11-12 Общество с ограниченной ответственностью "ГЕНОТЕК ИТ" Method for determining fetal karyotype in a pregnant woman
WO2020247263A1 (en) 2019-06-06 2020-12-10 Natera, Inc. Methods for detecting immune cell dna and monitoring immune system
CN114051534B (en) 2019-07-22 2025-02-21 贝克顿迪金森公司 Single-cell chromatin immunoprecipitation sequencing assay
CN114269948B (en) * 2019-08-30 2025-01-28 香港中文大学 Methods for detecting loss of heterozygosity by low-depth genome sequencing
US20240395357A1 (en) 2019-10-31 2024-11-28 Sequenom, Inc. Application of mosaicism ratio in multifetal gestations and personalized risk assessment
EP4407041A3 (en) 2019-11-08 2024-09-25 Becton Dickinson and Company Using random priming to obtain full-length v(d)j information for immune repertoire sequencing
EP4010495A1 (en) 2019-11-22 2022-06-15 Illumina, Inc. Circulating rna signatures specific to preeclampsia
US11649497B2 (en) 2020-01-13 2023-05-16 Becton, Dickinson And Company Methods and compositions for quantitation of proteins and RNA
EP4471155A3 (en) 2020-01-29 2024-12-18 Becton, Dickinson and Company Barcoded wells for spatial mapping of single cells through sequencing
CN115151810A (en) 2020-02-25 2022-10-04 贝克顿迪金森公司 Dual specificity probes enabling the use of single cell samples as monochromatic compensation controls
US12305242B2 (en) 2020-04-24 2025-05-20 The Johns Hopkins University Methods and related aspects for quantitative polymerase chain reaction to determine fractional abundance
CN115605614A (en) 2020-05-14 2023-01-13 贝克顿迪金森公司(Us) Primers for immune repertoire profiling
CN111534604B (en) * 2020-05-27 2024-01-23 广东华美众源生物科技有限公司 Fluorescent composite amplification kit for detecting human autosomal DIP-STR genetic marker
US12157913B2 (en) 2020-06-02 2024-12-03 Becton, Dickinson And Company Oligonucleotides and beads for 5 prime gene expression assay
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
US12391940B2 (en) 2020-07-31 2025-08-19 Becton, Dickinson And Company Single cell assay for transposase-accessible chromatin
EP4556574A3 (en) * 2020-09-11 2025-06-18 New England Biolabs, Inc. Application of immobilized enzymes for nanopore library construction
US11739443B2 (en) 2020-11-20 2023-08-29 Becton, Dickinson And Company Profiling of highly expressed and lowly expressed proteins
CN116157869A (en) 2020-12-02 2023-05-23 伊鲁米纳软件公司 Systems and methods for detecting genetic alterations
US12392771B2 (en) 2020-12-15 2025-08-19 Becton, Dickinson And Company Single cell secretome analysis
EP4409039A4 (en) * 2021-09-29 2025-09-03 Pillar Biosciences Inc Personalized cancer fluid biopsies with primers from a primer bank
EP4496900A2 (en) 2022-03-21 2025-01-29 BILLION ToONE, INC. Molecule counting of methylated cell-free dna for treatment monitoring
WO2024186778A1 (en) 2023-03-03 2024-09-12 Laboratory Corporation Of America Holdings Methods and systems for positive cfdna screening on genetic variations using mosaicism ratio
CN121153082A (en) 2023-05-15 2025-12-16 美国控股实验室公司 Machine learning method for pan cancer screening in whole genome sequencing
CN117965744B (en) * 2023-12-12 2024-10-11 东莞博奥木华基因科技有限公司 Kit, primer and method for detecting ploidy and maternal cell pollution of fetal samples based on multiplex PCR (polymerase chain reaction) capture technology
IL310301B1 (en) * 2024-01-21 2025-10-01 Identifai Genetics Ltd Methods for non-invasive prenatal testing of expansion mutations

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994057A (en) * 1992-07-30 1999-11-30 The Perkin-Elmer Corporation Method of detecting aneuploidy by amplified short-tandem repeats
US20060286558A1 (en) * 2005-06-15 2006-12-21 Natalia Novoradovskaya Normalization of samples for amplification reactions
US20070134658A1 (en) * 2003-03-05 2007-06-14 Genetic Technologies Limited, A.C.N. 009 212 328 Identification of fetal dna and fetal cell markers in maternal plasma or serum
US20080070792A1 (en) * 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US20090029377A1 (en) * 2007-07-23 2009-01-29 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
EP2334812A2 (en) * 2008-09-20 2011-06-22 The Board Of Trustees Of The University Of the Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
US5856097A (en) * 1992-03-04 1999-01-05 The Regents Of The University Of California Comparative genomic hybridization (CGH)
US5776737A (en) 1994-12-22 1998-07-07 Visible Genetics Inc. Method and composition for internal identification of samples
US6057103A (en) 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
CA2267795C (en) 1996-10-04 2011-04-05 Intronn Llc Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation
US20010051341A1 (en) 1997-03-04 2001-12-13 Isis Innovation Limited Non-invasive prenatal diagnosis
GB9704444D0 (en) 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
ATE364718T1 (en) 1997-04-01 2007-07-15 Solexa Ltd METHOD FOR DUPLICATION OF NUCLEIC ACID
US5888740A (en) 1997-09-19 1999-03-30 Genaco Biomedical Products, Inc. Detection of aneuploidy and gene deletion by PCR-based gene- dose co-amplification of chromosome specific sequences with synthetic sequences with synthetic internal controls
AR021833A1 (en) 1998-09-30 2002-08-07 Applied Research Systems METHODS OF AMPLIFICATION AND SEQUENCING OF NUCLEIC ACID
US6440706B1 (en) * 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
AU2001274869A1 (en) 2000-05-20 2001-12-03 The Regents Of The University Of Michigan Method of producing a dna library using positional amplification
US7062418B2 (en) 2000-06-27 2006-06-13 Fluidigm Corporation Computer aided design method and system for developing a microfluidic system
JP2004516813A (en) 2000-06-30 2004-06-10 インサイト・ゲノミックス・インコーポレイテッド Related tumor markers
US20020142324A1 (en) * 2000-09-22 2002-10-03 Xun Wang Fungal target genes and methods to identify those genes
US6951632B2 (en) 2000-11-16 2005-10-04 Fluidigm Corporation Microfluidic devices for introducing and dispensing fluids from microfluidic systems
US6691042B2 (en) 2001-07-02 2004-02-10 Rosetta Inpharmatics Llc Methods for generating differential profiles by combining data obtained in separate measurements
US7226732B2 (en) 2001-07-16 2007-06-05 Cepheid Methods, apparatus, and computer programs for verifying the integrity of a probe
US6927028B2 (en) 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
US7893248B2 (en) 2002-02-20 2011-02-22 Sirna Therapeutics, Inc. RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
CA2477611A1 (en) 2002-03-01 2003-09-12 Ravgen, Inc. Rapid analysis of variations in a genome
US6977162B2 (en) 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
US20030194704A1 (en) * 2002-04-03 2003-10-16 Penn Sharron Gaynor Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
US7727720B2 (en) 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
JP2006501449A (en) 2002-09-27 2006-01-12 ザ ジェネラル ホスピタル コーポレーション Microfluidic device for cell separation and use thereof
US10229244B2 (en) 2002-11-11 2019-03-12 Affymetrix, Inc. Methods for identifying DNA copy number changes using hidden markov model based estimations
ATE533857T1 (en) 2003-01-17 2011-12-15 Univ Hong Kong Chinese CIRCULATIVE MRNA AS A DIAGNOSTIC MARKER FOR DISEASES RELATED TO PREGNANCY
WO2004065617A2 (en) * 2003-01-17 2004-08-05 The Trustees Of Boston University Haplotype analysis
EP1594950A4 (en) 2003-01-29 2007-07-25 454 Corp Method for preparing single-stranded dna libraries
US20040209299A1 (en) 2003-03-07 2004-10-21 Rubicon Genomics, Inc. In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA
EP1649040A4 (en) 2003-07-10 2007-07-18 Third Wave Tech Inc Assays for the direct measurement of gene dosage
EP2354253A3 (en) 2003-09-05 2011-11-16 Trustees of Boston University Method for non-invasive prenatal diagnosis
US20050221341A1 (en) * 2003-10-22 2005-10-06 Shimkets Richard A Sequence-based karyotyping
WO2005072133A2 (en) * 2004-01-27 2005-08-11 Zoragen, Inc. Nucleic acid detection
US20100216153A1 (en) * 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
US20100216151A1 (en) * 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
US20060046258A1 (en) * 2004-02-27 2006-03-02 Lapidus Stanley N Applications of single molecule sequencing
EP1765503A2 (en) 2004-03-03 2007-03-28 The General Hospital Corporation System for delivering a diluted solution
WO2005116257A2 (en) 2004-05-17 2005-12-08 The Ohio State University Research Foundation Unique short tandem repeats and methods of their use
DE102004036285A1 (en) 2004-07-27 2006-02-16 Advalytix Ag Method for determining the frequency of sequences of a sample
JP2007327743A (en) 2004-09-07 2007-12-20 Univ Of Tokyo Gene copy analysis method and apparatus
TW200624106A (en) 2004-09-07 2006-07-16 Uni Charm Corp Warming article
US20060178835A1 (en) 2005-02-10 2006-08-10 Applera Corporation Normalization methods for genotyping analysis
US7645576B2 (en) 2005-03-18 2010-01-12 The Chinese University Of Hong Kong Method for the detection of chromosomal aneuploidies
AU2006256374A1 (en) 2005-06-08 2006-12-14 Compugen Ltd. Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
DE102005057988A1 (en) 2005-08-04 2007-02-08 Bosch Rexroth Ag axial piston
SI2385143T1 (en) 2006-02-02 2016-11-30 The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Non-invasive fetal genetic screening by digital analysis
ATE508209T1 (en) * 2006-02-28 2011-05-15 Univ Louisville Res Found DETECTION OF CHROMOSOME ABNORMALITIES IN THE FETUS USING TANDEM SINGLE NUCLEOTIDE POLYMORPHISMS
US20100184043A1 (en) 2006-02-28 2010-07-22 University Of Louisville Research Foundation Detecting Genetic Abnormalities
US20080064098A1 (en) * 2006-06-05 2008-03-13 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of maternal placental cells
CN101675169B (en) 2006-06-14 2018-01-02 维里纳塔健康公司 Rare Cell Analysis Using Sample Splitting and DNA Labeling
EP2589668A1 (en) * 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
EP2061801A4 (en) 2006-06-14 2009-11-11 Living Microsystems Inc Diagnosis of fetal abnormalities by comparative genomic hybridization analysis
EP2029778B1 (en) 2006-06-14 2018-05-02 Verinata Health, Inc Diagnosis of fetal abnormalities
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
WO2008014516A2 (en) 2006-07-28 2008-01-31 Living Microsystems, Inc. Selection of cells using biomarkers
US9328378B2 (en) * 2006-07-31 2016-05-03 Illumina Cambridge Limited Method of library preparation avoiding the formation of adaptor dimers
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8173370B2 (en) 2007-02-08 2012-05-08 Sequenom, Inc. Nucleic acid-based tests for RHD typing, gender determination and nucleic acid quantification
US12180549B2 (en) 2007-07-23 2024-12-31 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
EA201000427A1 (en) 2007-10-04 2010-10-29 Хэлсион Молекулар SEQUENCYING NUCLEIC ACID POLYMERS USING ELECTRON MICROSCOPY
ES2936256T3 (en) * 2008-02-01 2023-03-15 Massachusetts Gen Hospital Use of microvesicles in the diagnosis, and prognosis of diseases and medical conditions
US8709726B2 (en) * 2008-03-11 2014-04-29 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
US20090307180A1 (en) * 2008-03-19 2009-12-10 Brandon Colby Genetic analysis
WO2009120808A2 (en) * 2008-03-26 2009-10-01 Sequenom, Inc. Restriction endonuclease enhanced polymorphic sequence detection
US20090270601A1 (en) * 2008-04-21 2009-10-29 Steven Albert Benner Differential detection of single nucleotide polymorphisms
EP2315850B1 (en) * 2008-07-18 2015-02-25 TrovaGene, Inc. Methods for pcr-based detection of "ultra short" nucleic acid sequences
US20100285537A1 (en) 2009-04-02 2010-11-11 Fluidigm Corporation Selective tagging of short nucleic acid fragments and selective protection of target sequences from degradation
WO2011056094A2 (en) * 2009-10-26 2011-05-12 Общество С Ограниченной Ответственностью "Апoгeй" Fire valve
CA2778926C (en) * 2009-10-26 2018-03-27 Lifecodexx Ag Means and methods for non-invasive diagnosis of chromosomal aneuploidy
HUE061110T2 (en) * 2009-11-05 2023-05-28 Univ Hong Kong Chinese Fetal genome analysis from maternal biological sample
CA2777549A1 (en) 2009-11-12 2011-05-19 Esoterix Genetic Laboratories, Llc Copy number analysis of genetic locus
US20120270739A1 (en) 2010-01-19 2012-10-25 Verinata Health, Inc. Method for sample analysis of aneuploidies in maternal samples
CA2786565C (en) 2010-01-19 2017-04-25 Verinata Health, Inc. Partition defined detection methods
WO2011090556A1 (en) 2010-01-19 2011-07-28 Verinata Health, Inc. Methods for determining fraction of fetal nucleic acid in maternal samples
US9260745B2 (en) 2010-01-19 2016-02-16 Verinata Health, Inc. Detecting and classifying copy number variation
US20120237928A1 (en) 2010-10-26 2012-09-20 Verinata Health, Inc. Method for determining copy number variations
US10388403B2 (en) 2010-01-19 2019-08-20 Verinata Health, Inc. Analyzing copy number variation in the detection of cancer
EP2513341B1 (en) 2010-01-19 2017-04-12 Verinata Health, Inc Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
US20120100548A1 (en) 2010-10-26 2012-04-26 Verinata Health, Inc. Method for determining copy number variations
US9323888B2 (en) 2010-01-19 2016-04-26 Verinata Health, Inc. Detecting and classifying copy number variation
EP2848704B1 (en) 2010-01-19 2018-08-29 Verinata Health, Inc Sequencing methods for prenatal diagnoses
US20110312503A1 (en) 2010-01-23 2011-12-22 Artemis Health, Inc. Methods of fetal abnormality detection
PL2539450T3 (en) 2010-02-25 2016-08-31 Advanced Liquid Logic Inc Method of making nucleic acid libraries
WO2012012037A1 (en) * 2010-07-19 2012-01-26 New England Biolabs, Inc. Oligonucleotide adaptors: compositions and methods of use
US20120034603A1 (en) * 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
CN102409043B (en) 2010-09-21 2013-12-04 深圳华大基因科技服务有限公司 Method for constructing high-flux and low-cost Fosmid library, label and label joint used in method
KR101891847B1 (en) 2010-11-30 2018-08-24 더 차이니즈 유니버시티 오브 홍콩 Detection of genetic or molecular aberrations associated with cancer
EP2649199A2 (en) 2010-12-07 2013-10-16 Stanford University Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale
CN102127818A (en) 2010-12-15 2011-07-20 张康 Method for creating fetus DNA library by utilizing peripheral blood of pregnant woman
EP2655666A2 (en) 2010-12-23 2013-10-30 Sequenom, Inc. Fetal genetic variation detection
US20120190021A1 (en) 2011-01-25 2012-07-26 Aria Diagnostics, Inc. Detection of genetic abnormalities
CA2824387C (en) 2011-02-09 2019-09-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
RS57837B1 (en) 2011-04-12 2018-12-31 Verinata Health Inc Resolving genome fractions using polymorphism counts
GB2484764B (en) 2011-04-14 2012-09-05 Verinata Health Inc Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies
US9411937B2 (en) 2011-04-15 2016-08-09 Verinata Health, Inc. Detecting and classifying copy number variation
CA2840418C (en) 2011-07-26 2019-10-29 Verinata Health, Inc. Method for determining the presence or absence of different aneuploidies in a sample
CA2878246C (en) 2012-07-20 2022-01-11 Verinata Health, Inc. Detecting and classifying copy number variation in a cancer genome

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994057A (en) * 1992-07-30 1999-11-30 The Perkin-Elmer Corporation Method of detecting aneuploidy by amplified short-tandem repeats
US20070134658A1 (en) * 2003-03-05 2007-06-14 Genetic Technologies Limited, A.C.N. 009 212 328 Identification of fetal dna and fetal cell markers in maternal plasma or serum
US20060286558A1 (en) * 2005-06-15 2006-12-21 Natalia Novoradovskaya Normalization of samples for amplification reactions
US20080070792A1 (en) * 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US20090029377A1 (en) * 2007-07-23 2009-01-29 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
EP2334812A2 (en) * 2008-09-20 2011-06-22 The Board Of Trustees Of The University Of the Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Nature, Vol.456, 2008, Bentley, et al., "Accurate whole genome sequenceing...", pp.53-59 *
PNAS 105 (2008) Chiu et al'Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma' 20458-20463; PREV200900095046 *
PNAS 105 (2008) Fan et al Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood 16266-16271; NLM18838674 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10658070B2 (en) 2011-04-12 2020-05-19 Verinata Health, Inc. Resolving genome fractions using polymorphism counts
US8532936B2 (en) 2011-04-14 2013-09-10 Verinata Health, Inc. Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies

Also Published As

Publication number Publication date
DK3492601T3 (en) 2022-04-04
CA2785718A1 (en) 2011-07-28
AU2010343276A1 (en) 2012-09-06
EP2376661A1 (en) 2011-10-19
EP3878973A1 (en) 2021-09-15
US20240150828A1 (en) 2024-05-09
GB2479471A (en) 2011-10-12
EP3382037B1 (en) 2021-02-17
EP3006573A1 (en) 2016-04-13
AU2010343277B2 (en) 2015-05-28
GB201108795D0 (en) 2011-07-06
US20170327881A1 (en) 2017-11-16
AU2010343278B2 (en) 2015-05-21
US10941442B2 (en) 2021-03-09
ES2534986T3 (en) 2015-05-04
EP2366031A4 (en) 2012-03-21
EP3878973B1 (en) 2024-07-10
EP4450645A3 (en) 2025-01-22
EP2370599A4 (en) 2012-03-21
GB201118396D0 (en) 2011-12-07
EP3006573B1 (en) 2018-03-07
PL2376661T3 (en) 2015-06-30
US11952623B2 (en) 2024-04-09
US9657342B2 (en) 2017-05-23
AU2010343279A1 (en) 2012-09-06
AU2010343277A1 (en) 2012-09-06
DK2513339T3 (en) 2015-12-14
ES2704701T3 (en) 2019-03-19
EP2513339A1 (en) 2012-10-24
HK1162197A1 (en) 2012-08-24
GB2479476A (en) 2011-10-12
EP2883965B8 (en) 2018-06-27
EP3492601B1 (en) 2022-01-05
EP4074838A1 (en) 2022-10-19
US20170327883A1 (en) 2017-11-16
WO2011090558A1 (en) 2011-07-28
HK1170270A1 (en) 2013-02-22
TR201807917T4 (en) 2018-06-21
GB2479080A (en) 2011-09-28
GB2485644A (en) 2012-05-23
WO2011090557A1 (en) 2011-07-28
EP2513339B1 (en) 2015-09-09
US20110224087A1 (en) 2011-09-15
CY1124494T1 (en) 2022-07-22
EP3260555A1 (en) 2017-12-27
AU2010343276B2 (en) 2015-05-28
US11286520B2 (en) 2022-03-29
GB201118398D0 (en) 2011-12-07
EP3382037A1 (en) 2018-10-03
GB2485645B (en) 2012-11-21
EP2848703A1 (en) 2015-03-18
HK1177232A1 (en) 2013-08-16
CA2786351C (en) 2022-01-25
GB2485644B (en) 2012-11-21
EP2848704A1 (en) 2015-03-18
DK3382037T3 (en) 2021-05-25
EP3260555B1 (en) 2018-10-24
EP2513339A4 (en) 2013-05-29
EP3492601A1 (en) 2019-06-05
DK2376661T3 (en) 2015-02-02
GB201107268D0 (en) 2011-06-15
CA2786357C (en) 2018-08-21
HK1170269A1 (en) 2013-02-22
PL3260555T3 (en) 2019-05-31
US11130995B2 (en) 2021-09-28
CA2786544C (en) 2020-11-10
US20120094849A1 (en) 2012-04-19
US20170327884A1 (en) 2017-11-16
ES2870533T3 (en) 2021-10-27
US20110201507A1 (en) 2011-08-18
EP2848704B1 (en) 2018-08-29
HK1160185A1 (en) 2012-08-10
EP2370599B1 (en) 2015-01-21
CA2786357A1 (en) 2011-07-28
ES2534758T3 (en) 2015-04-28
GB2479476B (en) 2012-06-13
US11884975B2 (en) 2024-01-30
CA2786351A1 (en) 2011-07-28
DK3260555T3 (en) 2019-01-21
HK1160186A1 (en) 2012-08-10
EP2376661B1 (en) 2015-01-21
PL2366031T3 (en) 2015-08-31
EP2883965B1 (en) 2018-05-09
US20110245085A1 (en) 2011-10-06
PL3492601T3 (en) 2022-05-23
EP2366031B1 (en) 2015-01-21
EP4450645A2 (en) 2024-10-23
AU2010343279B2 (en) 2015-04-23
GB2479080B (en) 2012-01-18
CA2785718C (en) 2017-04-04
US20210340613A1 (en) 2021-11-04
WO2011090559A1 (en) 2011-07-28
AU2010343278A1 (en) 2012-09-06
US20120165203A1 (en) 2012-06-28
GB201108794D0 (en) 2011-07-06
EP2376661A4 (en) 2012-03-21
EP2366031A1 (en) 2011-09-21
GB2485645A (en) 2012-05-23
ES2560929T3 (en) 2016-02-23
US20220106639A1 (en) 2022-04-07
EP2883965A1 (en) 2015-06-17
DK2366031T3 (en) 2015-02-23
ES2909841T3 (en) 2022-05-10
US20220017958A1 (en) 2022-01-20
EP2370599A1 (en) 2011-10-05
CA2786544A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
GB2479471B (en) Method for determining copy number variations
IL234875B (en) Method for detecting copy number variation
GB2493514B (en) Copy detection
EP2628116A4 (en) Methods for estimating genome-wide copy number variations
EP2759601A4 (en) Gene copy number variation measurement method
GB201007159D0 (en) Method for evaluating anglogenic potential
HUE066534T2 (en) Method for determining reference unit
GB201001833D0 (en) Method
EP2637017A4 (en) Filling-capacity measuring method
GB201007353D0 (en) Method
IL222533A0 (en) Methods for detecting antibodies
GB201007354D0 (en) Method
GB201011513D0 (en) Method
GB201004759D0 (en) Method
EP2539469A4 (en) Methods for determining gene-nutrient interactions
GB2478186B (en) Electrophotographic apparatus
PL2753928T3 (en) Compositions and methods for detecting autoantibodies
EP2757373A4 (en) Method for measuring anti-wt1 antibody
EP2534839A4 (en) Method for processing image
GB201007522D0 (en) Method
HK1160186B (en) Method for determining copy number variations
GB201005447D0 (en) Apparatus for retaining
GB201009513D0 (en) Detection method
GB201118778D0 (en) Biomarker method
GB201119571D0 (en) Detection method

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1160186

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1160186

Country of ref document: HK

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20241201